Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients

Pediatric Research

Volumn 74, Issue 4, 2013, Pages 427-432

  Halstead, E Scott ^a   Carcillo, Joseph A ^b   Schilling, Bastian ^c   Greiner, Robert J ^a   Whiteside, Theresa L ^d  

^a PENN STATE CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL INFECTION; CELLULAR IMMUNODEFICIENCY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; MYCOSIS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VIRUS INFECTION;

ANTIGENS, CD56; CHILD, PRESCHOOL; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HUMANS; KILLER CELLS, NATURAL; PROSPECTIVE STUDIES; RECEPTORS, IGG; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84885677676     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.121     Document Type: Article

References (23)

1. Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pedi-atr Crit Care Med 2005;6:Suppl 3:S3-5.
2. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008;8:776-87.
3. Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse. I. Cyto-toxic cells with specifcity for mouse Moloney leukemia cells. Specifcity and distribution according to genotype. Eur J Immunol 1975;5:112-7.
4. Paust S, von Andrian UH. Natural killer cell memory. Nat Immunol 2011;12:500-8.
5. Cooper MA, Fehniger TA, Caligiuri MA. Te biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-40. (Pubitemid 33043908)
6. Mavilio D, Lombardo G, Benjamin J, et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci USA 2005;102:2886-91. (Pubitemid 40299886)
7. Alter G, Teigen N, Davis BT, et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005;106:3366-9. (Pubitemid 41609166)
8. Björkström NK, Ljunggren HG, Sandberg JK. CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol 2010;31:401-6.
9. Blazar BA, Rodrick ML, O'Mahony JB, et al. Suppression of natural killer-cell function in humans following thermal and traumatic injury. J Clin Immunol 1986;6:26-36. (Pubitemid 16128506)
10. Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ter 2005;7:R30-7.
11. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-6. (Pubitemid 36338013)
12. von Muller L, Klemm A, Durmus N, et al. Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis 2007;196:1288-95. (Pubitemid 351412000)
13. el-Sameea ER, Metwally SS, Mashhour E, et al. Evaluation of natural killer cells as diagnostic markers of early onset neonatal sepsis: comparison with C-reactive protein and interleukin-8. Egypt J Immunol 2004; 11: 91-102.
14. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: defnitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8.
15. Gonzalez VD, Falconer K, Björkström NK, et al. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. J Immunol 2009;183:6612-8.
16. Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, Johnson RP. CD16-natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 2010;115:4439-46.
17. Björkström NK, Lindgren T, Stoltz M, et al. Rapid expansion and longterm persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011;208:13-21.
18. Sieni E, Cetica V, Mastrodicasa E, et al. Familial hemophagocytic lympho-histiocytosis: a model for understanding the human machinery of cellular cytotoxicity. Cell Mol Life Sci 2012;69:29-40.
19. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957-9. (Pubitemid 129515904)
20. Aricò M, Allen M, Brusa S, et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br J Hae-matol 2002;119:180-8. (Pubitemid 35176519)
21. Marcenaro S, Gallo F, Martini S, et al. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 2006;108: 2316-23. (Pubitemid 44497515)
22. Kim GG, Donnenberg VS, Donnenberg AD, Gooding W, Whiteside TL. A novel multiparametric fow cytometry-based cytotoxicity assay simultaneously immunophenotypes efector cells: comparisons to a 4 h 51Cr-release assay. J Immunol Methods 2007;325:51-66. (Pubitemid 47238289)
23. Bryant J, Day R, Whiteside TL, Herberman RB. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods 1992;146:91-103.